Mitotic index to predict breast cancer recurrence after neoadjuvant systemic therapy.

被引：1
|
作者：
Farrugia, Daniel J.
Landmann, Alessandra
Diego, Emilia
McAuliffe, Priscilla F.
Johnson, Ronald
Bonaventura, Marguerite
Soran, Atilla
Dabbs, David J.
Clark, Beth
Puhalla, Shannon
Brufsky, Adam
Jankowitz, Rachel Catherine
Lembersky, Barry C.
Davidson, Nancy E.
Ahrendt, Gretchen M.
Bhargava, Rohit
机构：
[1] Natl Taiwan Univ, Ctr Genom Med, Taipei, Taiwan
[2] Dept Clin Lab Sci & Med Biotechnol, Taipei, Taiwan
[3] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e23265
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23265
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mitotic Index after Neoadjuvant Chemotherapy Prognosticates Breast Cancer Recurrence or Metastasis
    Harding-Jackson, Nicholas
    Hartley, Christopher
    Basir, Zainab
    MODERN PATHOLOGY, 2016, 29 : 45A - 45A
  • [2] Mitotic Index after Neoadjuvant Chemotherapy Prognosticates Breast Cancer Recurrence or Metastasis
    Harding-Jackson, Nicholas
    Hartley, Christopher
    Basir, Zainab
    LABORATORY INVESTIGATION, 2016, 96 : 45A - 45A
  • [3] Sentinel node biopsy in breast cancer after neoadjuvant therapy.
    Hauschild, M
    Thomas, A
    Maza, S
    Kuemmel, S
    Fischer, T
    Mallmann, P
    Munz, DL
    Blohmer, JU
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 49S - 49S
  • [4] Mammographic density to predict response to neoadjuvant systemic breast cancer therapy
    S. Di Cosimo
    C. Depretto
    R. Miceli
    P. Baili
    S. Ljevar
    M. Sant
    V. Cappelletti
    S. Folli
    M. Gennaro
    F. G. De Braud
    G. Bianchi
    A. Vingiani
    G. Pruneri
    A. Marchianò
    E. La Rocca
    M. C. De Santis
    G. P. Scaperrotta
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 775 - 781
  • [5] Mammographic density to predict response to neoadjuvant systemic breast cancer therapy
    Di Cosimo, S.
    Depretto, C.
    Miceli, R.
    Baili, P.
    Ljevar, S.
    Sant, M.
    Cappelletti, V
    Folli, S.
    Gennaro, M.
    De Braud, F. G.
    Bianchi, G.
    Vingiani, A.
    Pruneri, G.
    Marchiano, A.
    La Rocca, E.
    De Santis, M. C.
    Scaperrotta, G. P.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (04) : 775 - 781
  • [6] Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete response
    Xu, Yinggang
    Zhang, Weiwei
    Wang, Siqi
    Xu, Lu
    Xu, Haiping
    Chen, Rui
    Shi, Xiaoqing
    Huang, Xiaofeng
    Wang, Ye
    He, Jinzhi
    Shi, Wenjie
    Wan, Xinyu
    Wang, Jue
    Zha, Xiaoming
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity
    Suppan, Christoph
    Posch, Florian
    Mueller, Hannah Deborah
    Mischitz, Nina
    Steiner, Daniel
    Klocker, Eva Valentina
    Setaffy, Lisa
    Bargfrieder, Ute
    Hammer, Robert
    Hauser, Hubert
    Jost, Philipp J.
    Dandachi, Nadia
    Lax, Sigurd
    Balic, Marija
    CANCERS, 2021, 13 (10)
  • [8] Neoadjuvant systemic therapy for breast cancer
    Zaborowski, Alexandra M.
    Wong, Stephanie M.
    BRITISH JOURNAL OF SURGERY, 2023, 110 (07) : 765 - 772
  • [9] Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease
    Diaz, Janice
    Stead, Lesley
    Shapiro, Nella
    Newell, Rosanne
    Loudig, Olivier
    Lo, Yungtai
    Sparano, Joseph
    Fineberg, Susan
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (01) : 91 - 97
  • [10] Mitotic counts in breast cancer after neoadjuvant systemic chemotherapy and development of metastatic disease
    Janice Diaz
    Lesley Stead
    Nella Shapiro
    Rosanne Newell
    Olivier Loudig
    Yungtai Lo
    Joseph Sparano
    Susan Fineberg
    Breast Cancer Research and Treatment, 2013, 138 : 91 - 97
12345